DTP Branches and Offices
FDA-Approved Drugs
1949 | |
---|---|
1953 |
TEM (NSC 9706) |
1954 | |
1957 |
Chlorambucil (NSC 3088) * |
1959 |
Cyclophosphamide (NSC 26271) * |
1961 |
Vinblastine (NSC 49842) * |
1962 |
Uracil Mustard (NSC 34462) |
1963 |
Vincristine (NSC 67574) * |
1964 |
Melphalan (NSC 8806) * |
1966 |
Pipobroman (NSC 25154) * |
1967 |
Hydroxyurea (NSC 32065) * |
1969 |
Ara-C (NSC 63878) * |
1970 |
FUDR (NSC 27640) * |
1973 |
Bleomycin (NSC 125066) * |
1974 |
Adriamycin (NSC 123127) * |
1975 |
Dacarbazine (NSC 45388) * |
1976 |
CCNU (NSC 9037) * |
1977 | |
1978 |
cis-Platinum (NSC 119875) * |
1979 |
Daunomycin (NSC 82151) * |
1982 |
Streptozotocin (NSC 85998) * |
1983 |
Etoposide (NSC 141540) * |
1987 |
Mitoxantrone (NSC 301739) * |
1988 |
Ifosfamide (NSC 109724) * |
1989 |
Carboplatin (NSC 241240) * |
1990 |
Hexamethylmelamine (NSC 13875) * |
1991 |
Fludarabine Phosphate (NSC 312887) * |
1992 |
Chorodeoxyadenosine (NSC 105014) |
1994 |
Navelbine (NSC 608210) |
1995 |
All-t-retinoic acid (NSC 122758) * |
1996 |
Gemcitabine (NSC 613327) |
1998 |
Herceptin (NSC 688097) |
2000 |
Arsenic Trioxide (NSC 706363) |
2001 |
Gleevec (NSC 716051) |
2003 | |
2004 |
Clolar (NSC 606869) |
* Drugs marketed for oncology with DTP involvement